DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Sidoti & Co. Upgrades Anika Therapeutics to Buy, Announces $61 Price Target

Sidoti & Co. upgrades Anika Therapeutics (NASDAQ:ANIK) from Neutral to Buy and announces $61 price target.

Benzinga · 01/21/2020 14:15

Sidoti & Co. upgrades Anika Therapeutics (NASDAQ:ANIK) from Neutral to Buy and announces $61 price target.